Vivos Therapeutics Says New Dentist Inquiries To Participate In Vivos Integrated Practice Rose 600% From Prior Month, Signed Dentist Enrollment Contracts Increased 38% Over Q3
Portfolio Pulse from Benzinga Newsdesk
Vivos Therapeutics reports a 600% increase in new dentist inquiries to participate in its Integrated Practice program and a 38% rise in signed dentist enrollment contracts over Q3.
January 08, 2024 | 12:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Vivos Therapeutics experiences significant growth in dentist inquiries and enrollment, indicating increased adoption of its Integrated Practice program.
The substantial increase in new dentist inquiries and signed enrollment contracts suggests a growing interest and adoption of Vivos Therapeutics' Integrated Practice program. This could lead to higher revenue and market penetration in the short term, positively impacting VVOS stock.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100